← Live StudiesRegistry: recruitingPhase 3

Oral semaglutide dose study for weight management

Compares investigational lower once-daily doses of oral semaglutide with placebo tablets, to help choose a lower dose for weight management.

Who it's for

  • Age 18+
  • BMI ≥30, or ≥27 with a weight-related condition
  • Additional lab and medication restrictions

Full eligibility rules apply. The study team decides who can take part.

Where it runs

4 research locations in California and Hawaii.

California

  • Headlands Research California, LLCEscondido, CA
  • National Research Institute - Huntington ParkHuntington Park, CA
  • Los Angeles Institute for Metabolic ResearchLos Angeles, CA

Hawaii

  • East West Med Res InstHonolulu, HI

Site recruitment may change. The official record lists every location, including outside these states.

Interested in this study?

Ask us about it, or refer a patient. Taking part is voluntary, and the study team decides who can join.